Medicaid drug pricing – The Milli Chronicle

Monday, December 22, 2025

Latest:

Factual Version of a Story

Featured News World

NewsDesk Milli Chronicle December 21, 2025December 21, 2025 affordable medicines America, drug price transparency, drugmaker government deal, healthcare cost reduction, lower prescription costs, Medicaid drug pricing, Medicaid medicine savings, medicine price reform, most favored nation pricing, patient access medicines, pharma industry collaboration, pharmaceutical investment USA, pharmaceutical pricing agreement, prescription drug affordability, prescription savings plan, Trump healthcare policy, TrumpRx platform, US drug policy update, US drug price cuts, US healthcare reform

Trump and Leading Drugmakers Reach Landmark Agreement to Lower Medicine Prices

New partnership promises affordability, innovation, and broader access to essential medicines. The United States has taken a major step toward

Featured News World

NewsDesk Milli Chronicle November 7, 2025 affordable medicine USA, CMS Medicaid initiative, drug price comparison, Generous Model program, healthcare accessibility, healthcare savings, international drug pricing model, low-income healthcare support, Medicaid affordability program, Medicaid drug pricing, Medicaid spending reform, pharmaceutical rebates, prescription drug cost reduction, prescription drug savings, U.S. healthcare initiative 2026, US government healthcare reform

US Government Launches Generous Model to Cut Medicaid Prescription Costs

The U.S. government’s newly launched “Generous Model” marks a pivotal step in reshaping Medicaid’s prescription drug pricing, aiming to make